HB 1367 establishes a Commission on Re-Imagining Health Care in Maryland to study and recommend changes for a new statewide healthcare system. The commission, composed of 20 appointed members including state officials, healthcare providers, insurers, county representatives, and community members, will examine how healthcare is delivered in other regions and address issues like provider shortages, cost balancing, and system integration. It will specifically study how to create a patient-centered system covering all health needs, eliminate access barriers, and ensure financial sustainability for all Maryland residents. The commission’s final recommendations, due by 2028, would guide potential future policy changes but do not enact any immediate healthcare reforms.
HB 1533 (the Crown and Care Act) bans 12 specific harmful ingredients - including certain phthalates, formaldehyde, mercury, and PFAS chemicals - from cosmetic products sold in Maryland. It directly affects cosmetic manufacturers, retailers, and salons by prohibiting the sale or distribution of products containing these ingredients, with limited exceptions for unavoidable trace amounts from manufacturing processes. The bill authorizes the Maryland Department of Health to investigate complaints, inspect businesses, and enforce penalties, while allowing consumers harmed by violations to seek civil damages and attorney fees. This law aims to protect public health by reducing exposure to chemicals linked to health risks like skin irritation and potential long-term harm.
SB 656 bans 12 specific harmful chemicals in cosmetics sold in Maryland, including formaldehyde, mercury, and certain PFAS chemicals. It creates civil liability for manufacturers or sellers who violate this ban, allowing consumers to sue for damages. The Maryland Department of Health gains authority to investigate complaints, inspect businesses, and collect product samples. The law exempts trace amounts of banned ingredients that occur unavoidably during manufacturing. The bill takes effect July 1, 2026.
SB 773 allows pharmacists in Maryland to order certain vaccinations (like flu, COVID-19, or emergency vaccines) for patients aged 3 and older without needing to administer the vaccine themselves. To qualify, pharmacists must complete 20 hours of approved training, hold current CPR certification, and complete 2 hours of continuing education on immunizations. The bill requires pharmacists to follow written vaccine-specific protocols, report all vaccinations to Maryland’s ImmuNet registry, and refer pediatric patients to primary care providers when appropriate. This policy directly affects pharmacists, patients seeking these vaccines, and healthcare coordination for immunizations. The changes take effect October 1, 2026.
SB 412 establishes Maryland’s Community Forensic Aftercare Program within the Maryland Department of Health. The program monitors two groups: individuals committed to the health department due to being "not criminally responsible" (often called "not guilty by reason of insanity" cases), and people with mental illness or intellectual disability requiring community monitoring under specific legal circumstances. Key mechanisms include creating a community monitoring board to decide on conditional release and out-of-state travel, and requiring licensed social workers ("Program Monitors") to track compliance with court orders and make health recommendations. The bill amends Maryland’s Criminal Procedure and Health codes to implement this program, focusing on safety and structured oversight for these individuals.
SB 411 requires non-state hospitals in Maryland to establish clinical staffing committees with equal representation from management and frontline staff, including nurses, technicians, and other caregivers. These committees must develop evidence-based staffing plans considering patient acuity, staffing gaps, and daily patient needs, which hospitals must implement starting January 1, 2028. Hospitals must annually review these plans, publicly post staffing data on units, and submit annual reports to the Maryland Health Care Commission beginning in 2030. The bill directly affects hospital operations, staffing decisions, and transparency for frontline workers and patients.
HB 624 (Safe Staffing Act of 2026) requires most Maryland hospitals to establish clinical staffing committees with equal management and employee representation, including specific frontline staff like nursing assistants and dietary aides. These committees must develop annual staffing plans considering patient acuity, staffing gaps, and evidence-based standards, then post the plans publicly and update them yearly. Hospitals must implement these plans starting in 2028, allow staff to file complaints about violations, and report annually to the Maryland Health Care Commission beginning in 2030. The law directly affects licensed hospitals and frontline healthcare workers by mandating structured, transparent staffing processes to address patient care needs.
HB 280 codifies Maryland’s health insurance requirements for mental health and substance use disorder coverage to align with federal parity laws. It requires health insurers to collect and report data on access to these services, explain differences in coverage rules, and comply with federal standards for equal treatment. The Maryland Insurance Commissioner will review insurer reports and address noncompliance. This bill directly affects health insurance companies and their policyholders seeking mental health or substance use disorder care.
HB 498 removes an existing exemption that allowed intermediate care facilities providing substance use disorder treatment to change bed capacity without a certificate of need. It specifically targets facilities offering "medically managed residential substance use disorder treatment services," requiring them to file 45 days' written notice with the health commission before operating or expanding. The commission must then review and approve these changes based on whether they align with the state health plan, improve service efficiency, and serve the public interest. This bill directly affects facilities providing residential substance use treatment by adding a review process for bed capacity changes or new operations, replacing the previous exemption.
SB 866 requires chain restaurants with 20 or more locations in Maryland to display warning icons next to menu items exceeding 1,150mg sodium or 25mg added sugars per serving, starting January 1, 2028. The Maryland Department of Health must create these icons and guidelines by January 1, 2027, and run a public education campaign during 2027 to explain compliance. The bill directly affects large chain restaurants by mandating clear labeling of high-sodium and high-sugar menu items. It defines "high sodium" as 1,150mg per serving and "high added sugars" as 25mg per serving for labeling purposes.